康诺亚与阿斯利康合作推进 CMG901获4500万美元里程碑付款

ITBEAR科技资讯
Yesterday

近日,康诺亚对外披露了一则重要公告,其与阿斯利康(AstraZeneca)就核心产品CMG901(AZD0901)的合作有了新进展。阿斯利康宣布,已正式启动一项名为CLARITY - Gastric02的多中心、随机对照、III期临床研究。该研究聚焦于AZD0901联合卡培他滨,联合或不联合rilvegostomig,用于一线治疗Claudin18.2阳性、HER2阴性的晚期或转移性胃癌、胃食管...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10